Anebulo Pharmaceuticals (ANEB) Stock Chart & Stock Price History → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free ANEB Stock Alerts $2.78 -0.07 (-2.46%) (As of 04/19/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Anebulo Pharmaceuticals Stock Price Performance5 Day Performance-4.30%1 Month Performance+15.83%3 Month Performance+15.83%6 Month Performance-3.14%Year-To-Date Performance+14.88%1 Year Performance-6.08% Receive ANEB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Anebulo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. ANEB Stock Chart for Friday, April, 19, 2024 ANEB Chart by TradingView Anebulo Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/19/2024$2.75$2.78+1.09%$2.79$2.75711 shs$71.25 million04/18/2024$3.00$2.75-8.33%$3.30$2.754,903 shs$70.48 million04/17/2024$2.96$3.00+1.35%$3.00$2.78992 shs$76.89 million04/16/2024$2.96$2.96$2.96$2.96222 shs$75.87 million04/15/2024$2.91$2.96+1.89%$3.08$2.961,717 shs$75.87 million04/12/2024$2.89$2.96+2.42%$3.07$2.8010,120 shs$75.87 million Get the Latest News and Ratings for ANEB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Anebulo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/11/2024$2.60$2.89+11.15%$2.89$2.612,079 shs$74.07 million04/10/2024$2.71$2.60-4.06%$2.60$2.602,550 shs$66.64 million04/09/2024$2.78$2.71-2.52%$2.98$2.7127,625 shs$69.46 million04/08/2024$2.78$2.78-0.01%$3.10$2.781,688 shs$71.26 million04/05/2024$2.91$2.78-4.47%$3.09$2.7619,089 shs$71.25 million04/04/2024$2.88$2.91+1.04%$2.91$2.84222 shs$74.58 million04/03/2024$2.83$2.88+1.77%$3.00$2.805,151 shs$73.81 million04/02/2024$3.04$2.83-6.91%$2.97$2.724,238 shs$72.53 million04/01/2024$2.87$3.04+5.92%$3.14$2.877,914 shs$77.92 million03/29/2024$2.87$2.87$3.09$2.873,912 shs$73.56 million03/28/2024$2.78$2.87+3.24%$3.09$2.873,912 shs$73.56 million03/27/2024$2.60$2.78+6.92%$3.05$2.6111,234 shs$71.25 million03/26/2024$2.50$2.60+4.10%$2.71$2.602,755 shs$66.64 million03/25/2024$2.50$2.50-0.10%$2.50$2.455,029 shs$64.01 million03/22/2024$2.40$2.50+4.17%$2.50$2.401,188 shs$64.08 million03/21/2024$2.40$2.40$2.40$2.40961 shs$61.51 million03/20/2024$2.40$2.40$2.52$2.402,761 shs$61.51 million03/19/2024$2.40$2.40$2.50$2.405,784 shs$61.52 million03/18/2024$2.54$2.40-5.51%$2.51$2.403,837 shs$61.51 million03/15/2024$2.42$2.54+4.96%$2.68$2.4216,651 shs$65.10 million03/14/2024$2.42$2.42$2.42$2.42770 shs$62.03 million03/13/2024$2.45$2.42-1.22%$2.56$2.423,661 shs$62.03 million03/12/2024$2.77$2.45-11.55%$2.76$2.4514,111 shs$62.79 million03/11/2024$2.95$2.77-6.10%$2.77$2.77589 shs$71.00 million03/08/2024$2.91$2.95+1.37%$2.95$2.807,442 shs$75.61 million03/07/2024$2.74$2.91+6.20%$3.10$2.705,313 shs$74.58 million03/06/2024$2.87$2.74-4.53%$2.74$2.74415 shs$70.23 million03/05/2024$2.87$2.87$3.21$2.7912,802 shs$73.56 million03/04/2024$2.75$2.87+4.36%$3.17$2.756,411 shs$73.56 million03/01/2024$2.72$2.75+1.10%$2.85$2.752,447 shs$70.48 million02/29/2024$2.82$2.72-3.55%$3.14$2.722,277 shs$69.72 million02/28/2024$2.72$2.82+3.67%$2.83$2.723,633 shs$72.28 million02/27/2024$2.72$2.72$3.12$2.7011,724 shs$69.72 million02/26/2024$2.85$2.72-4.56%$3.12$2.7011,724 shs$69.72 millionBiden’s $374B Giveaway Into This Sector (Ad)Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story02/23/2024$2.90$2.85-1.72%$3.00$2.856,119 shs$73.05 million02/22/2024$3.00$2.90-3.23%$3.08$2.909,567 shs$74.33 million02/21/2024$2.98$3.00+0.57%$3.12$3.00973 shs$76.81 million02/20/2024$2.85$2.98+4.56%$3.15$2.845,751 shs$76.38 million02/19/2024$2.85$2.85$3.30$2.6228,300 shs$73.05 million02/16/2024$2.75$2.80+1.82%$3.30$2.6228,338 shs$71.76 million02/15/2024$2.72$2.75+1.10%$2.77$2.75514 shs$70.49 million02/14/2024$2.58$2.72+5.43%$2.72$2.582,673 shs$69.71 million02/13/2024$2.46$2.58+4.88%$2.63$2.4616,365 shs$66.13 million02/12/2024$2.48$2.46-0.81%$2.68$2.464,015 shs$63.05 million02/09/2024$2.47$2.48+0.40%$2.70$2.4715,812 shs$63.56 million02/08/2024$2.57$2.47-3.89%$2.65$2.452,960 shs$63.31 million02/07/2024$2.67$2.57-3.75%$2.57$2.57513 shs$65.87 million02/06/2024$2.56$2.67+4.30%$2.69$2.473,664 shs$68.43 million02/05/2024$2.56$2.56$2.56$2.56336 shs$65.61 million02/02/2024$2.57$2.56-0.39%$2.56$2.453,076 shs$65.61 million02/01/2024$2.58$2.57-0.19%$2.70$2.572,400 shs$65.87 million01/31/2024$2.52$2.58+2.18%$2.58$2.4814,256 shs$66.01 million01/30/2024$2.49$2.52+1.20%$2.58$2.4510,600 shs$64.59 million01/29/2024$2.43$2.49+2.68%$2.57$2.498,515 shs$63.82 million01/26/2024$2.40$2.43+1.04%$2.43$2.43233 shs$62.16 million01/25/2024$2.42$2.40-0.83%$2.40$2.40284 shs$61.51 million01/24/2024$2.40$2.42+0.83%$2.42$2.42339 shs$62.03 million01/23/2024$2.40$2.40$2.41$2.40982 shs$61.51 million01/22/2024$2.40$2.40$2.45$2.402,397 shs$61.51 million01/19/2024$2.40$2.40$2.48$2.40797 shs$61.51 million01/18/2024$2.52$2.40-4.76%$2.50$2.401,860 shs$61.51 million Related Companies: Q32 Bio Stock Price Chart Equillium Stock Price Chart Kronos Bio Stock Price Chart Landos Biopharma Stock Price Chart MediciNova Stock Price Chart Checkpoint Therapeutics Stock Price Chart Eagle Pharmaceuticals Stock Price Chart Immuneering Stock Price Chart Eliem Therapeutics Stock Price Chart Immix Biopharma Stock Price Chart Receive ANEB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Anebulo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ANEB) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceOptions trading has suddenly become more reliable.Eagle PublishingHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anebulo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.